This collaboration combines Euroclone's consolidated presence in the Italian market, and advanced genomic profiling solutions of Gene⁺, a long-term partner of MGI. Together, we are committed to:

- To simplify the access and reproducibility of genomic profiling in molecular pathology.

- Contribute to the definition of Personalized Precision Medicine treatments.

- Offer All-in-One NGS packages for the entire patient journey, from cancer risk assessment to diagnosis, prognosis, and treatment monitoring.

Learn more about GenePlus solutions for oncology.

https://lnkd.in/gYNy4ZSQ

#MolecularDiagnostic #Partnership #Innovation #PrecisionMedicine